IMforte: A Phase III Study of Lurbinectedin and Atezolizumab Versus Atezolizumab as Maintenance Therapy in ES-SCLC

Paz-Ares, L; Reck, M; Peters, S; Borghaei, H; Herbst, R; Siddiqui, M; Cuchelkar, V; Bhatt, K; Chakrabarti, D; Wang, L; Morris, S; Liu, SV

JOURNAL OF THORACIC ONCOLOGY, 2022; 17 (9): S532

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索